Global Printing establishes blockchain subsidiary to achieve traceability of pharmaceutical anti-counterfeiting and supply chain management

Global Printing (002799) established a blockchain subsidiary to implement anti-counterfeiting traceability of medicines and supply chain management. In December 2019, the company and Beijing Aisirite jointly invested in the establishment of a blockchain technology enterprise. The company will use Beijing Aisirite's technology advantages in big data to improve production automation and strengthen information construction. At the same time, based on the traceability of blockchain technology and the transfer of digital assets, the functions of anti-counterfeiting and anti-channeling of products can be realized, which can be applied to the anti-counterfeiting of pharmaceuticals and supply chain management.